{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:24:35Z","timestamp":1767147875171,"version":"build-2238731810"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T00:00:00Z","timestamp":1544745600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"name":"Ministry of Science & Technology","award":["MOST107-2314-B075-051-MY3"],"award-info":[{"award-number":["MOST107-2314-B075-051-MY3"]}]},{"DOI":"10.13039\/501100011912","name":"Taipei Veterans General Hospital","doi-asserted-by":"crossref","award":["V107D37- 002-MY3, VN106-01"],"award-info":[{"award-number":["V107D37- 002-MY3, VN106-01"]}],"id":[{"id":"10.13039\/501100011912","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Microbiology, Immunology and Infection"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.jmii.2018.12.002","type":"journal-article","created":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T20:28:02Z","timestamp":1544905682000},"page":"114-121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The clinical features and mortality risk factors of cytomegalovirus infection in patients with systemic lupus erythematosus"],"prefix":"10.1016","volume":"52","author":[{"given":"MingLi","family":"Hung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deh-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chien-Chih","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Han","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsien-Tzung","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Youh","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmii.2018.12.002_bib1","first-page":"189","article-title":"Cellular and molecular basis of the protective immune response to cytomegalovirus infection","volume":"154","author":"Koszinowski","year":"1990","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jmii.2018.12.002_bib2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-6143.2004.00692.x","article-title":"Canadian society of transplantation consensus workshop on cytomegalovirus management in solid organ transplantation: final report","volume":"5","author":"Preiksaitis","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jmii.2018.12.002_bib3","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1128\/JCM.34.2.457-459.1996","article-title":"High level sensitivity of quantitative pp65 cytomegalovirus (CMV) antigenemia assay for diagnosis of CMV disease in AIDS patients and follow-up","volume":"34","author":"Bek","year":"1996","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jmii.2018.12.002_bib4","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1182\/blood.V80.5.1358.1358","article-title":"Cytomegalovirus antigen detection in peripheral blood leukocytes after allogeneic marrow transplantation","volume":"80","author":"Boeckh","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.jmii.2018.12.002_bib5","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/0961203316671817","article-title":"Disseminated cytomegalovirus infection complicating active treatment of systemic lupus erythematosus: an emerging problem","volume":"26","author":"Berman","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.jmii.2018.12.002_bib6","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.2169\/internalmedicine.55.5981","article-title":"Cytomegalovirus reactivation induced acute hepatitis and gastric erosions in a patient with rheumatoid arthritis under treatment with an anti-IL-6 receptor antibody, tocilizumab","volume":"55","author":"Komura","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.jmii.2018.12.002_bib7","first-page":"538137","article-title":"Fatal cytomegalovirus disease after combination therapy with corticosteroids and rituximab for granulomatosis with polyangiitis","volume":"2015","author":"Hilal","year":"2015","journal-title":"Case Rep Rheumatol"},{"key":"10.1016\/j.jmii.2018.12.002_bib8","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1007\/s00296-011-2131-4","article-title":"Cytomegalovirus infection causes morbidity and mortality in patients with autoimmune diseases, particularly systemic lupus: in a Chinese population in Taiwan","volume":"32","author":"Tsai","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.jmii.2018.12.002_bib9","first-page":"1349","article-title":"Incidence of cytomegalovirus reactivation in patients with inflammatory connective tissue diseases who are under immunosuppressive therapy","volume":"31","author":"Mori","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jmii.2018.12.002_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00006982-199515020-00015","article-title":"Cytomegalovirus retinitis in a patient with rheumatoid arthritis being treated with combination immunosuppressive therapy","volume":"15","author":"Fraenkel","year":"1995","journal-title":"Retina"},{"key":"10.1016\/j.jmii.2018.12.002_bib11","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1093\/rheumatology\/ken231","article-title":"Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population","volume":"47","author":"Takizawa","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/j.jmii.2018.12.002_bib12","article-title":"Predictors of mortality in autoimmune disease patients with concurrent cytomegalovirus infections detected by quantitative real-time PCR","volume":"25","author":"Lee","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jmii.2018.12.002_bib13","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jmii.2018.12.002_bib14","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Diagnostic and therapeutic criteria committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jmii.2018.12.002_bib15","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1002\/art.34473","article-title":"Derivation and validation of systemic lupus international collaborating Clinics classification criteria for systemic lupus erythematosus","volume":"64","author":"Petri","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jmii.2018.12.002_bib16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2147\/DDDT.S41645","article-title":"Rituximab for the treatment of rheumatoid arthritis: an update","volume":"8","author":"Mok","year":"2013","journal-title":"Drug Design Devel Ther"},{"key":"10.1016\/j.jmii.2018.12.002_bib17","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.jmii.2018.12.002_bib18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"The development and validation of the SLE disease activity index (SLEDAI)","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jmii.2018.12.002_bib19","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1473-3099(04)01202-2","article-title":"Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments","volume":"4","author":"Gandhi","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jmii.2018.12.002_bib20","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/RHU.0b013e3181f4cf52","article-title":"Cytomegalovirus as a trigger for systemic lupus erythematosus","volume":"16","author":"P\u00e9rez-Mercado","year":"2010","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.jmii.2018.12.002_bib21","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1080\/08916930500285352","article-title":"Infections and SLE","volume":"38","author":"Zandman-Goddard","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jmii.2018.12.002_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nri700","article-title":"Modelling viral and immune system dynamics","volume":"2","author":"Perelson","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jmii.2018.12.002_bib23","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1182\/blood-2012-10-459545","article-title":"NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs","volume":"121","author":"B\u00e9ziat","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jmii.2018.12.002_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nri.2016.38","article-title":"T cell responses to cytomegalovirus","volume":"16","author":"Klenerman","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jmii.2018.12.002_bib25","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1097\/00002030-200309050-00005","article-title":"Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection","volume":"17","author":"Fiebig","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.jmii.2018.12.002_bib26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2174\/187152611797636703","article-title":"Overview of the diagnosis of cytomegalovirus infection","volume":"11","author":"Ross","year":"2011","journal-title":"Infect Disord Drug Target"},{"key":"10.1016\/j.jmii.2018.12.002_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/CMR.00015-13","article-title":"Clinical utility of viral load in management of cytomegalovirus infection after solid organ transplantation","volume":"26","author":"Razonable","year":"2013","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jmii.2018.12.002_bib28","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/S0140-6736(00)02350-3","article-title":"Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation","volume":"355","author":"Emery","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jmii.2018.12.002_bib29","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/j.1600-6143.2012.04087.x","article-title":"Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy","volume":"12","author":"Atabani","year":"2012","journal-title":"Am J Transplant"}],"updated-by":[{"DOI":"10.1016\/j.jmii.2019.05.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000}}],"container-title":["Journal of Microbiology, Immunology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118218301208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1684118218301208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T15:25:32Z","timestamp":1590161132000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1684118218301208"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S1684118218301208"],"URL":"https:\/\/doi.org\/10.1016\/j.jmii.2018.12.002","relation":{},"ISSN":["1684-1182"],"issn-type":[{"value":"1684-1182","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The clinical features and mortality risk factors of cytomegalovirus infection in patients with systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Journal of Microbiology, Immunology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmii.2018.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}